Published on 29/11/2025

SPC in PPQ vs CPV: Different Purposes, Different Rules

Understanding Statistical Process Control (SPC) in the context of Process Performance Qualification (PPQ) and Continued Process Verification (CPV) is imperative for pharmaceutical professionals involved in quality assurance and regulatory compliance. This guide will detail the purposes, rules, and specific applications of SPC, particularly focusing on PPQ and CPV methodologies, acceptable quality levels (AQL), process capability indices (Cp, Cpk), and how these elements interplay with current regulatory standards.

1. Introducing SPC in the Pharmaceutical Context

Statistical Process Control (SPC) serves as a vital framework for monitoring and controlling manufacturing processes to ensure product quality and compliance with regulatory standards. In the pharmaceutical industry, SPC techniques are applied to various stages of the product lifecycle, particularly during Process Performance Qualification (PPQ) and Continued Process Verification (CPV).

PPQ occurs during the final stages of process validation where actual manufacturing processes are confirmed to produce products meeting predetermined specifications. On the other hand, CPV is an ongoing procedure that continuously assesses production processes to ensure that they remain in a state of control throughout the product lifecycle. Understanding the implications and differences of SPC in these two contexts is essential for maintaining compliance with regulatory expectations established by authorities such as the FDA, the European Medicines Agency (EMA), and the Medicines and Healthcare products Regulatory Agency (MHRA).

2. Framework of Process Performance Qualification (PPQ)

PPQ is a critical component in ensuring that a manufacturing process is capable of consistently producing a product that meets quality attributes. The implementation of a robust PPQ sampling plan is central to this validation phase. For an effective sampling strategy within PPQ, the following steps should be undertaken:

• Define the Batch Size: Understand the total quantity of the product being produced, as this greatly impacts the sampling strategy.
• Determine the Sampling Plan: Utilize either attribute sampling (using AQL) or variable sampling (using Cpk) based on the critical quality attributes established for the product.
• Establish Acceptance Criteria: Define specific criteria for acceptability that align with regulatory expectations and product specifications.
• Conduct Sampling: Implement the chosen sampling plan during the PPQ execution phase, ensuring randomness and adequacy in sample size for representation.
• Analyze Data: Use SPC control charts to assess outcome variability and determine if processes are stable and in control.
• Report Findings: Document all results and establish a rationale for the acceptance criteria based on statistical and regulatory meetings.

The role of AQL vs. Cpk is of paramount importance during the PPQ phase. AQL provides a threshold for the number of defective items in a batch, whereas Cpk assesses process capability indicating how well the process produces items within specified limits. A robust sample plan must articulate clearly which method is used and under what circumstances, ensuring regulatory compliance as per guidelines outlined in EU GMP Annex 15.

3. Continued Process Verification (CPV) Explained

Continued Process Verification (CPV) is implemented post-approval to ensure consistent quality and compliance throughout the lifecycle of the product. The following steps outline the structure of CPV:

• Establish Continuous Monitoring: Define the metrics and key process parameters that will be monitored continuously during production, such as process capability indices.
• Utilize SPC Control Charts: Deploy control charts as a foundation to analyze process performance over time, take note of any signals that indicate a process drift or loss of control.
• Investigate Out-of-Control Signals: Develop an escalation tree for investigating any signals or trends that deviate from established control limits, ensuring root cause analysis and corrective/preventive actions are documented.
• Review Historical Data: Regularly review historical data to confirm that the process remains reproducible and produces consistent quality products.
• Update Validation Documentation: Maintain adequate documentation of all CPV activities, assuring that changes and results are communicated to stakeholders and regulatory agencies.

The CPV process addresses the need for ongoing verification of the control strategy, aligning with ICH Q9 risk management principles. By systematically reviewing processes through SPC techniques, organizations can substantiate their compliance and process maturity.

4. Key Differences Between PPQ and CPV

While both PPQ and CPV are integral to maintaining product quality, they embody distinct purposes and differ significantly in their methodologies:

• Time of Application: PPQ is applied during the validation phase of a new product, ensuring that the process can meet defined specifications before commercial launch; CPV, however, is sustained through the product’s life cycle.
• Focus: PPQ emphasizes establishing and documenting that the process is capable of consistent output. In contrast, CPV aims at continual assessment and verification of the ongoing process performance.
• Sampling Plans: PPQ typically employs a structured sampling plan aimed at confirming initial process capability, while CPV may leverage a continuous or dynamic approach to sampling based on risk assessments.
• Regulatory Expectations: Both processes must adhere to regulatory guidelines; however, the focus of PPQ is more on initial validation, while CPV concentrates on maintaining compliance throughout the product’s life cycle.

5. Practical Application of SPC Signals in PPQ and CPV

The practical application of SPC signals is a cornerstone of both PPQ and CPV. Each signal drawn from the control charts helps determine deviations from the expected process behavior, guiding actions that are crucial for upholding process quality.

Within the framework of PPQ, organizations should prepare to identify immediate signals that trigger investigation, whilst during CPV, the focus would shift towards long-term trends that could indicate process deterioration. Understanding the types of control charts, such as X-bar and R charts, is essential to leverage these signals effectively. The analysis results should be documented thoroughly to justify acceptance criteria and serve as a basis for continuous improvement strategies.

6. Acceptance Criteria Justification

Integral to both PPQ and CPV is the development of acceptance criteria which dictate whether a batch meets the requirements set forth by regulatory bodies. Justifying these criteria requires a comprehensive understanding of statistical principles and the application of capability indices such as Cp and Cpk. The justification process should involve:

• Historical Data Review: Analyzing past production data to inform realistic acceptance levels for the current process.
• Statistical Analysis: Utilizing statistical methods to establish thresholds that are both achievable and aligned with regulatory expectations.
• Stakeholder Collaboration: Engaging cross-functional teams—technical, quality, regulatory—to ensure that acceptance criteria are agreed upon and set for consistency.
• Documentation: Providing a solid rationale that traces back to performance data, ensuring that all stakeholders understand the indicators used for sample acceptance during PPQ and throughout CPV.

Ultimately, these justifications must reflect a balance between acceptable risk and regulatory compliance, establishing confidence in the processes employed.

7. Summary of Best Practices for PPQ and CPV

In conclusion, understanding the distinct roles of SPC in PPQ versus CPV is essential for ensuring the delivery of high-quality pharmaceutical products. By implementing best practices, organizations can leverage both methodologies effectively:

• Design Comprehensive Sampling Plans: Based on both AQL and Cpk assessments to create defensible quality controls.
• Focus on Continuous Improvement: Through CPV, ensuring ongoing adjustments and improvements are made based on real-time data.
• Engage in Effective Communication: Ensure all changes, results, and observations are documented and communicated transparently across respective stakeholders.
• Embed SPC Practices into Culture: Foster a culture of quality, where team members view quality as a shared responsibility embedded within their roles.

By adhering to these guidelines, pharmaceutical professionals can ensure that their processes not only meet but exceed regulatory standards, thus facilitating a robust approach to product quality assurance.